1. Home
  2. HUBB vs PODD Comparison

HUBB vs PODD Comparison

Compare HUBB & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hubbell Inc

HUBB

Hubbell Inc

HOLD

Current Price

$439.93

Market Cap

23.2B

Sector

Technology

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$304.59

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBB
PODD
Founded
1888
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2B
22.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
HUBB
PODD
Price
$439.93
$304.59
Analyst Decision
Buy
Strong Buy
Analyst Count
6
19
Target Price
$474.00
$359.00
AVG Volume (30 Days)
464.2K
765.6K
Earning Date
10-28-2025
11-06-2025
Dividend Yield
1.29%
N/A
EPS Growth
15.10
N/A
EPS
15.99
3.45
Revenue
$5,686,200,000.00
$2,521,800,000.00
Revenue This Year
$5.89
$32.55
Revenue Next Year
$7.65
$20.39
P/E Ratio
$27.55
$88.24
Revenue Growth
0.82
27.11
52 Week Low
$299.43
$230.05
52 Week High
$484.26
$354.88

Technical Indicators

Market Signals
Indicator
HUBB
PODD
Relative Strength Index (RSI) 54.20 40.94
Support Level $422.10 $303.20
Resistance Level $432.90 $317.34
Average True Range (ATR) 11.19 13.12
MACD 1.16 -2.82
Stochastic Oscillator 92.59 3.14

Price Performance

Historical Comparison
HUBB
PODD

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, electrical substations, and within commercial and industrial buildings. The company's primary operations are within the United States, where around 90% of revenue is derived.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: